Increased matrix metalloproteinase 2 concentration and transcript expression in advanced colorectal carcinomas

International Journal of Colorectal Disease

Volumn 16, Issue 3, 2001, Pages 133-140

  Chan, C C ^a   Menges, M ^a   Orzechowski, H D ^a   Orendain, N ^a   Pistorius, G ^a   Feifel, G ^a   Zeitz, M ^a   Stallmach, A ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Colorectal cancer; Invasion; Matrix metalloproteinases; Metastasis; Tissue inhibitors of metalloproteinases

Indexed keywords

GELATINASE A; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADVANCED CANCER; ARTICLE; CANCER INVASION; CANCER STAGING; COLON; COLORECTAL CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME DEFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE MUCOSA; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RECTUM; STROMA; TISSUE LEVEL; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; WESTERN BLOTTING;

BLOTTING, WESTERN; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IN SITU HYBRIDIZATION; MATRIX METALLOPROTEINASE 2; NEOPLASM PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 0034955359     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003840100287     Document Type: Article

References (47)

1. Tumor invasion: A consequence of destructive and compositional matrix alterations
2. Metalloproteinases and their inhibitors in matrix remodeling
3. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
4. Overview of expression of matrix metalloproteinases (MMP-17, MMP-18, and MMP-20) in cultured human cells
5. Matrix metalloproteinases
6. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
7. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2
8. Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor
9. Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines: Not an invariant correlation with metastasis
10. Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression
11. Increased expression of the Mr 72:0000 type IV collagenase in human colonic adenocarcinoma
12. Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal carcinomas
13. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer
14. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma
15. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MTI-MMP) correlate with melanoma progression
16. Matrix metalloproteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain neoplasms
17. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer
18. Staging of cancer of the colon and rectum
19. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies
20. Comparable expression of matrix-metalloproteinases-1 and -2 in pouchitis and ulcerative colitis
21. Structure of the human type IV collagenase gene
22. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction
23. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues
24. Expression of CD44v6 is associated with cellular dysplasia in colorectal epithelial cells
25. Secretion of type IV collagenolytic protease and metastatic phenotype: Induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a
26. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases
27. Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion
28. Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma
29. In situ hybridisation studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer
30. Evidence for increased activated metalloproteinases (MMP-2a) expression associated with human prostate cancer progression
31. Prognostic significance of circulating matrix metalloproteinases-2 to tissue inhibitor of metalloproteinases-2 ratio in recurrence of urothel cancer after complete resection
32. Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo
33. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas
34. Role of collagenases in tumor cell invasion
35. Proteolytic enzymes in tumor metastasis. II. Collagenase type IV activity in subcellular fractions of cloned tumor cell populations
36. Type IV collagenase activity of a primary HSV-2-induced hamster fibrosarcoma and its in vivo metastases and in vitro clones
37. Stimulation of TIMP-1 and metalloproteinase production in co-cultures of human tumor cells and human fibroblasts
38. Membrane association of collagenase stimulatory factor(s) from B-16 melanoma cells
39. Monoclonal antibody preparation and purification of a tumor cell collagenase stimulatory factor
40. Tumor cell-derived collagenase stimulatory factor (TCSF) increases expression of interstitial collagenase, stromelysin, and 72 kDa gelatinase
41. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily
42. Modulation of the invasive phenotype of human colon carcinoma cells by organ specific fibroblasts in nude mice
43. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
44. Matrix metalloproteinases 2 (MMP-2) and matrix metalloproteinases 9 (MMP-9) type IV collagenases in colorectal cancer
45. Increased type-IV collagenase (MMP-2 and MMP-9) activity following preoperative radiotherapy in rectal cancer
46. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2
47. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice